Variable | ADa completed | ADa not completed | Entire sample |
---|---|---|---|
n = 76 | n = 152 | n = 228 | |
mean (SD) | mean (SD) | mean (SD) | |
Age (in years)* | 85.76 (7.02) | 83.31 (6.88) | 84.13 (7.01) |
Baseline QoLb (EQ-5D 3 L score)* | 0.41 (0.31) | 0.49 (0.29) | 0.46 (0.30) |
Baseline functional status (Barthel Index) | 57.46 (21.4) | 60.99 (20.70) | 59.81 (20.95) |
Baseline cognitive function SMMSEc score) | 22.24 (5.54) | 23.63 (4.97) | 23.17 (5.22) |
Baseline depressive symptoms (GDS-15d score)* | 5.84 (2.97) | 4.30 (2.97) | 4.80 (3.05) |
Body mass index (BMI)e | 24.03 (5.79) | 24.47 (5.86) | 24.32 (5.83) |
n (%) | n (%) | n (%) | |
Gender (female) | 44 (58) | 94 (62) | 138 (61) |
Individuals with a QoLf gain over 12 months | 28 (42) | 67 (48) | 95 (46) |
Individuals dead at 12 months | 18 (24) | 35 (23) | 53 (23) |
Place of death | |||
Hospital | 10 (56) | 21 (60) | 31 (58) |
Residential Care/Respite | 8 (44) | 11 (31) | 19 (36) |
Home/Independent | 0 (0) | 3 (9) | 3 (6) |
Living unit | |||
Type of ADa completed (%) | |||
GPCPg | 35 (46) | ||
EPGh | 21 (28) | ||
MDi | 20 (26) | ||
When AD was completedj | |||
Before admission to TCk | 22 (30) | ||
During admission to TCk | 51 (70) | ||
Trial Arm | |||
Intervention* | 53 (70) | 63 (41) | 116 (51) |
Usual care* | 23 (30) | 89 (59) | 112 (49) |